Chemical Formula: C30H30O13
Chemical Formula C30H30O13
Found 19 metabolite its formula value is C30H30O13
Jacaglabroside B
[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate
(2S)-6,8-dimethyl-5,7,2,5-tetrahydroflavanone 7-O-(6-O-p-hydroxybenzoyl)-beta-D-glucopyranoside|myrciacitrin V
(2S)-6,8-dimethyl-5,7,2,5-tetrahydroflavanone 7-O-(6-O-p-hydroxybenzoyl)-beta-D-glucopyranoside|myrciacitrin V
{3,4,5-triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-6-yloxy]-2H-3,4,5,6-te trahydropyran-2-yl}methyl acetate
{3,4,5-triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-6-yloxy]-2H-3,4,5,6-te trahydropyran-2-yl}methyl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.356 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.355
[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate
NCGC00347589-02![(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate
Myrciacitrin V
Myrciacitrin V
A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2 and 5, methyl groups at positions 6 and 8 and a (6-O-p-hydroxybenzoyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.
(6-{[2-(2,5-dihydroxyphenyl)-5-hydroxy-6,8-dimethyl-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxybenzoate
(6-{[2-(2,5-dihydroxyphenyl)-5-hydroxy-6,8-dimethyl-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxybenzoate
4-{[4-(acetyloxy)-2,9,10-trihydroxy-8-(5-hydroxy-6-methyloxan-2-yl)-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid
4-{[4-(acetyloxy)-2,9,10-trihydroxy-8-(5-hydroxy-6-methyloxan-2-yl)-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid
(4r,5s,14s)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
(4r,5s,14s)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
4-{[(2s,3r,4s)-4-(acetyloxy)-2,9,10-trihydroxy-8-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid
4-{[(2s,3r,4s)-4-(acetyloxy)-2,9,10-trihydroxy-8-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid
[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate
[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-{[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy}-5-[(2-phenylacetyl)oxy]oxan-2-yl]methyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate
(4r,5s,14r)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
(4r,5s,14r)-4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
4,14-bis(3,4-dihydroxyphenyl)-8-hydroxy-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-12-one
[3,4,5-Triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl acetate
[3,4,5-triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl acetate
